The Antibody Engineering and Therapeutics series, hosted by Informa Connect, is a premier global event dedicated to advancing the field of antibody-based therapeutics.
Posted on May 30, 2025
1 minute read
Antibody Therapeutics, the official journal of Chinese Antibody Society, published by Oxford University Press, has been accepted by Clarivate for indexing in the Emerging Sources Citation Index (ESCI).
1 minute read
Read Story
We extend an invitation for the submission of abstracts for the 2024 Annual Conference through our dedicated portal at www.casconferenceposter.org.
1 minute read
Read Story
Chinese Antibody Society (CAS) is a proud partner of Cambridge Healthtech Institute (CHI), organizer of a series of renowned meetings related to antibody therapeutics
1 minute read
Read Story
We will continue to provide comprehensive analysis and reports about therapeutic antibody licensing deals between Chinese biopharma and overseas companies. In this third business report on this topic, we focus on licensing deals closed in 2022.
9 minutes read
Read Story
Embed your knowledge on key antibody concepts, applications and strategies, or upskill the entire team, on Informa Connect Life Science’s most popular course
less than a minute read
Read Story
Fourty antibody deals were closed at a total value of ~ $14.7 billion in 2021. Twenty two of them were in-licensing deals; eighteen were out-licensing deals.
1 minute read
Read Story
Canada ranks fourth in global health and biosciences hubs. Canadian biotech companies are nimble, dynamic, and focused. In this article, we will take a deep dive into some of the m
less than a minute read
Read Story
We are excited to announce that PharmaDJ and the Chinese Antibody Society will collaborate to provide comprehensive analysis and reports about therapeutic antibody licensing deals between Chinese biopharma and overseas companies.
1 minute read
Read Story
The digital FcRn-Targeted Therapies for Autoimmune Disorders Summit will be virtually held from 23-25, March 2021
less than a minute read
Read Story
Oxford University Press and the Chinese Antibody Society are pleased to announce their new partnership to launch the journal Antibody Therapeutics this spring.
2 minutes read
Read Story
10% off registration fee for CAS members when registering for 2021 CHI Meetings
less than a minute read
Read Story
The Chinese Antibody Society (CAS) and the organizing committee of the Antibody Engineering & Therapeutics (AET) conference have entered into a collaboration
1 minute read
Read Story
The Chinese Antibody Society and Cambridge Healthtech Institute Announce Strategic Partnership
2 minutes read
Read Story